One linked filing — more sources may join as they report · filed Apr 30, 2026. View entity profile → Other incidents for this victim →
incident inc_29d1640b1f0b4bf5 · merge_method deterministic
Not recorded for this incident
Discovery variance · Leak precedence · Materiality delta · SEC filing delay · Filing span — no leak-site claim in this cluster; needs two dated filings.
FEDERAL
all SEC 10-K Item 1C
Earliest sighting first · deep chronology in Litigation Timeline
This is a Form 10-K/A (Amendment No. 1) filed by Jasper Therapeutics, Inc. (Nasdaq: JSPR) on April 30, 2026, amending the Annual Report for fiscal year ended December 31, 2025. The amendment solely adds Part III (Items 10–14) governance disclosures omitted from the original 10-K. No cybersecurity incident or breach is disclosed in this filing.
About this clustering
DisclosureLens links filings into incidents through layered matchers: deterministic rules (same source document, multistate filings of one breach, tight-window same-victim pairs), a weighted-similarity scorer for cross-source candidates, and an operator review queue for everything uncertain. Each link records its own method and confidence — shown per filing in the timeline below. The system defaults to NOT merging when uncertain, because a false merge (collapsing two unrelated breaches) is more harmful than a false split (showing related filings separately); uncertain pairs route to human review instead of auto-merging. Filing summaries shown in the timeline are AI-generated extracts — verify each against its linked source.